Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 11 papers were listed this time. Here's a handful in our areas of our research interest:
Lazar LD, Pletcher MJ, Coxson PG, et al. Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era. Circulation. 2011 Jun 27. [Epub ahead of print] PubMed PMID: 21709063.
Delea TE, Tappenden P, Sofrygin O, et al. Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab. Eur J Health Econ. 2011 Jun 24. [Epub ahead of print] PubMed PMID: 21701940.
Hiligsmann M, Reginster JY. Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium. Pharmacoeconomics. 2011 Jun 21. [Epub ahead of print] PubMed PMID: 21692551.
